1. Home
  2. GMM vs XGN Comparison

GMM vs XGN Comparison

Compare GMM & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Mofy Metaverse Limited

GMM

Global Mofy Metaverse Limited

HOLD

Current Price

$1.46

Market Cap

70.6M

Sector

N/A

ML Signal

HOLD

Logo Exagen Inc.

XGN

Exagen Inc.

HOLD

Current Price

$3.49

Market Cap

71.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GMM
XGN
Founded
2017
2002
Country
China
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.6M
71.2M
IPO Year
2022
2014

Fundamental Metrics

Financial Performance
Metric
GMM
XGN
Price
$1.46
$3.49
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$8.86
AVG Volume (30 Days)
1.0M
425.4K
Earning Date
01-09-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$8.12
Revenue Next Year
N/A
$13.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.94
$2.59
52 Week High
$3.29
$12.23

Technical Indicators

Market Signals
Indicator
GMM
XGN
Relative Strength Index (RSI) 56.65 55.11
Support Level $1.41 $2.68
Resistance Level $1.59 $3.97
Average True Range (ATR) 0.18 0.33
MACD 0.02 0.07
Stochastic Oscillator 72.69 54.73

Price Performance

Historical Comparison
GMM
XGN

About GMM Global Mofy Metaverse Limited

Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital asset development for the metaverse industry. The Company leverages its proprietary Mofy Lab technology platform, which integrates three-dimensional (3D) reconstruction technology and artificial intelligence (AI) interactive technology, to create high-definition virtual versions of physical world objects, including humans, animals, and scenes. It provides comprehensive technology solutions to support virtual content production for use across movies, television series, animation, advertising, and gaming. The Company operates through Virtual Technology Services, which generates the majority of revenue, and Digital Asset Development and others.

About XGN Exagen Inc.

Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

Share on Social Networks: